|
US6265564B1
(en)
|
1996-08-02 |
2001-07-24 |
Regeneron Pharmaceuticals, Inc. |
Expressed ligand-vascular intercellular signalling molecule
|
|
US6348350B1
(en)
|
1997-09-19 |
2002-02-19 |
Genentech, Inc. |
Ligand homologues
|
|
US6030831A
(en)
*
|
1997-09-19 |
2000-02-29 |
Genetech, Inc. |
Tie ligand homologues
|
|
AU4643699A
(en)
*
|
1998-06-24 |
2000-01-10 |
Compugen Ltd. |
Angiopoietin-like growth factor sequences
|
|
CA2354846A1
(en)
*
|
1998-12-23 |
2000-06-29 |
Regeneron Pharmaceuticals, Inc. |
Method of enhancing the biological activity of ligands
|
|
US6455035B1
(en)
|
1999-03-26 |
2002-09-24 |
Regeneron Pharmaceuticals, Inc. |
Angiopoietins and methods of use thereof
|
|
EP1253928A4
(en)
*
|
2000-01-20 |
2005-06-15 |
Hadasit Med Res Service |
NEW HAPTOTACTIC PEPTIDES
|
|
NZ523882A
(en)
|
2000-08-21 |
2004-11-26 |
Pacific Corp |
Novel thiourea derivatives and the pharmaceutical compositions containing the same
|
|
WO2002022176A1
(en)
|
2000-09-15 |
2002-03-21 |
Genvec, Inc. |
Method of modulating neovascularization
|
|
US7205275B2
(en)
|
2001-10-11 |
2007-04-17 |
Amgen Inc. |
Methods of treatment using specific binding agents of human angiopoietin-2
|
|
US7521053B2
(en)
|
2001-10-11 |
2009-04-21 |
Amgen Inc. |
Angiopoietin-2 specific binding agents
|
|
US7138370B2
(en)
|
2001-10-11 |
2006-11-21 |
Amgen Inc. |
Specific binding agents of human angiopoietin-2
|
|
US7658924B2
(en)
|
2001-10-11 |
2010-02-09 |
Amgen Inc. |
Angiopoietin-2 specific binding agents
|
|
AU2002335085A1
(en)
|
2001-10-25 |
2003-05-06 |
Regeneron Pharmaceuticals, Inc. |
Angiopoietins and methods of use thereof
|
|
AU2002359464A1
(en)
*
|
2001-11-30 |
2003-06-17 |
Genvec, Inc. |
Angiopioetin related factors
|
|
US7081443B2
(en)
|
2002-05-21 |
2006-07-25 |
Korea Advanced Institutes Of Science And Technology (Kaist) |
Chimeric comp-ang1 molecule
|
|
US7569543B2
(en)
*
|
2003-02-27 |
2009-08-04 |
The Trustees Of The University Of Pennsylvania |
Compositions of Angiopoietin, fragments, mutants and analogs thereof and uses of the same
|
|
WO2005013890A2
(en)
*
|
2003-05-29 |
2005-02-17 |
The Trustees Of The University Of Pennsylvania |
Function and regulation of angiopoietin-3/angiopoietin-4
|
|
US7871610B2
(en)
*
|
2003-08-12 |
2011-01-18 |
Dyax Corp. |
Antibodies to Tie1 ectodomain
|
|
US7485297B2
(en)
*
|
2003-08-12 |
2009-02-03 |
Dyax Corp. |
Method of inhibition of vascular development using an antibody
|
|
CA2535171A1
(en)
*
|
2003-08-12 |
2005-03-03 |
Dyax Corp. |
Tie1-binding ligands
|
|
CN1323723C
(zh)
*
|
2003-12-26 |
2007-07-04 |
上海新世界基因技术开发有限公司 |
Tie2受体介导的靶向性肿瘤基因治疗的基因转移系统
|
|
US8298532B2
(en)
|
2004-01-16 |
2012-10-30 |
Regeneron Pharmaceuticals, Inc. |
Fusion polypeptides capable of activating receptors
|
|
ZA200705695B
(en)
|
2004-12-21 |
2009-02-25 |
Astrazeneca Ab |
Antibodies directed to angiopoietin-2 and uses thereof
|
|
US20080213253A1
(en)
*
|
2007-01-12 |
2008-09-04 |
Dyax Corp. |
Combination therapy for the treatment of cancer
|
|
JO2913B1
(en)
|
2008-02-20 |
2015-09-15 |
امجين إنك, |
Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses
|
|
WO2009158432A2
(en)
|
2008-06-27 |
2009-12-30 |
Amgen Inc. |
Ang-2 inhibition to treat multiple sclerosis
|
|
JP5727458B2
(ja)
*
|
2009-04-13 |
2015-06-03 |
アプセト ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフトApceth Gmbh & Co. Kg |
改変間葉系幹細胞及びそれを使用した腫瘍の治療方法
|
|
DK2714738T3
(en)
|
2011-05-24 |
2019-01-28 |
Zyngenia Inc |
MULTIVALENT AND MONOVALENT MULTISPECIFIC COMPLEXES AND THEIR APPLICATIONS
|
|
KR101967345B1
(ko)
*
|
2012-10-18 |
2019-04-09 |
삼성전자주식회사 |
안지오포이에틴-2와 인테그린 간의 결합을 저해하는 펩타이드 및 그 용도
|
|
MX2015013163A
(es)
|
2013-03-15 |
2016-04-04 |
Zyngenia Inc |
Complejos multiespecificos multivalente y monovalentes y sus usos.
|
|
RU2538701C1
(ru)
*
|
2013-07-11 |
2015-01-10 |
Федеральное государственное бюджетное учреждение науки "Тюменский научный центр Сибирского отделения РАН" (ТюмНЦ СО РАН) |
Способ извлечения куриного эмбриона из яйца для дальнейшего получения клеточных трансплантатов из фетальных тканей
|
|
BR112017005730B1
(pt)
|
2014-09-26 |
2023-12-12 |
Somalogic Operating Co., Inc |
Método para triagem de um indivíduo quanto ao risco de um evento cardiovascular ou para predizer a probabilidade que um indivíduo tenha tal evento
|
|
WO2017079556A1
(en)
|
2015-11-06 |
2017-05-11 |
Regeneron Pharmaceuticals, Inc. |
Use of angiopoietins in promoting blood coagulation and in the treatment of blood coagulation disorders
|